Patient and general practitioner perspectives of the hospital outreach medication review service at monash health

Journal of Pharmacy Practice and Research

Volumn 45, Issue 3, 2015, Pages 282-290

  Hanna, Mary ^a   Larmour, Ian ^a   Wilson, Sally ^b,c   O’Leary, Karen ^b  

^a SOUTHERN HEALTH   (Australia)

^b Soc of Hosp Pharmacists Australia   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

HMR; HOMR; Medication review; Outreach

Indexed keywords

AGED; CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; GENERAL PRACTITIONER; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PERCEPTION; PHARMACIST; PHARMACY; PROFESSIONAL PRACTICE; QUESTIONNAIRE; RISK ASSESSMENT;

EID: 84958048330     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr.1115     Document Type: Article

References (18)

1. Australian Commission on Safety and Quality in Health Care (ACSQHC). Australian safety and quality goals for health care. Medication safety action guide. Sydney: ACSQHC; 2012.
2. Elliott RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pract Res 2006; 36: 58-66.
3. Alvarez S, Larmour I, Tapley N, Buick M, Greene L, Hines L, et al. Education outreach to the community: does hospital pharmacy have a role? Aust J Hosp Pharm 2001; 31: 13-17.
4. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PRS, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30: 205-11.
5. Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting. Results of a cohort study. Circ Heart Fail 2009; 2: 424-8.
6. Woodgate J, Jones J, Ford D, Garrett K, Morehen J. The medication alert project [abstract]. Proceedings of the 27th Federal Conference of the Society of Hospital Pharmacists of Australia; 2005 Nov 10-13; Brisbane, Queensland. Brisbane: The Society; 2005.
7. Kongkaew C, Hann M, Mandal J, Williams SD, Metcalfe D, Noyce PR, et al. Risk factors for hospital admissions associated with adverse drug events. Pharmacotherapy 2013; 3: 827-37.
8. Atkin PA, Veitch PC, Veitch EM, Ogle SJ. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 1999; 14: 141-52.
9. Blennerhassett J, Hilbers J. Medicine management in older people from non-english speaking backgrounds. J Pharm Pract Res 2011; 41: 33-6.
10. Australian Pharmaceutical Advisory Council. Guiding principles to achieve continuity in medication management. Australian Pharmaceutical Advisory Council: Canberra; 2005.
11. The Society of Hospital Pharmacists of Australia. SHPA committee of specialty practice in clinical pharmacy. SHPA standards of practice for clinical pharmacy. J Pharm Pract Res 2013; 43: S2-73.
12. Quirke J, Wheatland B, Gilles M, Howden A, Larson A. Home medicines reviews - do they change prescribing and patient/ pharmacist acceptance? Aust Fam Physician 2006; 35: 266-7.
13. Sorensen L, King MA, Peck R, Roberts MS. In-home medication reviews for war veterans: early experiences in Australia. J Pharm Pract Res 2004; 34: 122-4.
14. Nguyen A, Yu K, Shakib S, Doecke CJ, Boyce M, March G, et al. Classification of findings in the home medicine reviews of postdischarge patients at risk of medication misadventure. J Pharm Pract Res 2007; 37: 111-14.
15. Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M, et al. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev 2014; Issue 4: CD007768.
16. Campbell Research & Consulting. Home medicines review program, qualitative research project. Final report. Canberra: Department of Health and Ageing; 2008.
17. Fejzic JB, Tett SE. Medication management reviews for people from the former Yugoslavia nowresident in Australia. Pharm World Sci 2004; 26: 271-6.
18. Carter SR, Chen TF, White L. Home medicines reviews: a quantitative study of the views of recipients and eligible non-recipients. Int J Pharm 2012; 20: 209-17.